In March 2025, the vitamin market experienced a light procurement demand, with market prices running relatively stable, and the transaction price for vitamin E stopped falling and slightly rebounded.
On 24 March, 2025, Hubei Guangji Pharmaceutical Co., Ltd.'s subsidiary received a strategic investment of USD34.85 million (RMB250.00 million), planning to spin off the loss-making vitamin B6 business.
On 12 March, 2025, according to the China Trade Remedy Information Network, India has made a final anti-dumping ruling on Vitamin A Palmitate involving China.
On 27 Feb., 2025, the Ministry of Agriculture and Rural Affairs of the People's Republic of China, the National Health Commission, and the Ministry of Industry and Information Technology of the People's Republic of China jointly issued the China Food and Nutrition Development Outline (2025–2030).
Project progress of many companies:
- Wanhua Chemical's Vitamin A project
- Weirong Pharmaceutical's 400 kg/a vitamin D2 project
- FY Feed Tech's vitamin B2 quality optimization and upgrade project
The USD/RMB exchange rate in this Report is USD1.00=CNY7.1745 on 3 March 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
